“The results from the American study show that over a period of 7 to 10 years, [PSA] screening did not reduce the death rate in men 55 and over,” said Richard J. Ablin, PhD, a research professor of immunobiology and pathology at the University of Arizona College of Medicine and the president of the Robert Benjamin Ablin Foundation for Cancer Research, who discovered PSA (prostate-specific antigen) in 1970.
“The European study showed a small decline in death rates, but also found that 48 men would need to be treated to save one life.”
“That’s 47 men who, in all likelihood, can no longer function sexually or stay out of the bathroom for long.”
He wrote this in an Op-Ed in The New York Times in 2010 which was titled The Great Prostate Mistake.
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.